SOP FOR CONTAMINATION CONTROL STRATEGY (CCS)

SOP FOR CONTAMINATION CONTROL STRATEGY (CCS)

1.0 OBJECTIVE

1.1 To describe the procedure for establishing, implementing, and maintaining a comprehensive Contamination Control Strategy (CCS) to ensure that risks of microbial, particulate, and endotoxin/pyrogen contamination are systematically identified, evaluated, controlled, monitored, and continuously improved in accordance with the principles of EU GMP Annex 1.

2.0 SCOPE

2.1 This SOP is applicable to all sterile manufacturing areas including:

• Grade A/B aseptic processing zones

• Grade C/D support areas

• Cleanroom utilities and equipment

• Personnel practices

• Environmental monitoring systems

• Cleaning and disinfection activities

• Gowning and sterilization activities

• Material and component flow

• HVAC and air handling systems

• Maintenance and engineering support

• Pest control and facility hygiene

2.2 This SOP covers all departments involved in product manufacturing including Production, QA, QC, Engineering, Validation, and Housekeeping.

3.0 RESPONSIBILITY

3.1 Quality Assurance (QA)

• Establish, maintain, review, and approve the CCS document.

• Review contamination trends, deviations, risk assessments, and CAPA.

• Ensure compliance with EU GMP Annex 1 requirements.

3.2 Production

• Implement CCS controls during routine manufacturing.

• Ensure proper gowning, aseptic practices, and execution of cleaning procedures.

3.3 Quality Control (QC) & Microbiology

• Perform environmental and microbiological monitoring.

• Review alert and action limit excursions and initiate investigations where required.

3.4 Engineering & Utility Team

• Maintain controlled environments including HVAC systems, HEPA filters, and pressure differentials.

• Ensure timely calibration, qualification, and preventive maintenance of equipment and utilities.

3.5 Housekeeping & Sanitation

• Execute cleaning and disinfection programs as per approved procedures.

3.6 All Personnel

• Comply with CCS requirements and aseptic behavior standards at all times.

4.0 ACCOUNTABILITY

4.1 Head – QA shall be accountable for overall implementation and compliance of this SOP.

4.2 All concerned department heads shall be accountable for implementation and adherence within their respective areas.

5.0 DEFINITION & ABBREVIATION

5.1 Definitions

• CCS: Contamination Control Strategy – A structured, holistic, and documented set of controls designed to prevent contamination.

• Aseptic Area: Area where sterile product is exposed to the environment.

• Bioburden: Microbial load present prior to sterilization.

• RABS: Restricted Access Barrier System.

• EM Program: Environmental Monitoring system for viable and non-viable contaminants.

5.2 Abbreviations

6.0 PRECAUTIONS, SAFETY & EHS

6.1 Not Applicable (Refer to relevant EHS and Safety SOPs).

7.0 MATERIALS & EQUIPMENT REQUIRED

7.1 Not Applicable (Refer to respective departmental SOPs).

8.0 PROCEDURE

8.1 Establishment of Contamination Control Strategy

8.1.1 A CCS document shall be created, reviewed, and approved to define contamination risks and corresponding controls across the facility.

8.1.2 The CCS shall be developed using:

• Quality Risk Management principles (ICH Q9)

• EU GMP Annex 1 sterility assurance requirements

• Historical data, deviations, investigations, and product quality trends

8.2 Key CCS Elements

8.2.1 Facility Design and Layout

• Maintain unidirectional personnel and material flow.

• Ensure segregation of Grade A/B zones from lower-grade areas.

• Maintain proper zoning, airlocks, and pressure cascades.

• Provide smooth, cleanable, non-shedding surfaces.

8.2.2 HVAC System and Airflow Control

• HEPA filters shall be qualified and integrity-tested at defined intervals.

• Laminar airflow velocity shall be maintained in Grade A areas.

• Differential pressures shall be continuously monitored with alarm systems.

• Temperature and humidity shall be maintained within defined limits.

8.2.3 Cleaning and Disinfection Program

• Disinfectant rotation shall include:

  • Broad-spectrum disinfectant

  • Sporicide

• Cleaning schedules shall define:

  • Frequency

  • Responsible personnel

  • Cleaning method

  • Contact time

• Effectiveness of disinfectants shall be verified periodically through microbiological challenge studies.

8.2.4 Equipment and Material Transfer

• Defined procedures shall govern transfer of components, equipment, and tools.

• Approved sterilization methods include:

  • Autoclaving

  • Dry heat sterilization

  • VHP sterilization

• All materials shall be cleaned and sanitized prior to transfer.

8.2.5 Personnel Gowning and Training

• Only trained and qualified personnel shall enter Grade A/B areas.

• Gowning requirements include:

  • Sterile garments

  • Sterile gloves

  • Masks

  • Goggles

• Personnel shall undergo periodic gowning qualification and aseptic behavior assessments.

8.2.6 Aseptic Practices and Process Simulation

• Manual interventions shall be minimized.

• Media fill studies shall be conducted semi-annually for each aseptic line.

• All operator interventions shall be documented and risk assessed.

8.2.7 Environmental Monitoring (EM)

• Viable and non-viable monitoring shall be conducted in Grade A–D areas.

• Alert and action limits shall be established as per room grade.

• Routine monitoring shall include:

  • Airborne particles

  • Viable microorganisms

  • Surface contamination

  • Personnel gown contamination

• EM excursions shall be investigated and trended.

8.2.8 Water Systems & Utilities

• PW and WFI systems shall be monitored for bioburden and endotoxins.

• Compressed gases (air, nitrogen) shall be sterile and filtered.

8.2.9 Validation and Qualification

• Qualification shall include:

  • HVAC systems

  • Autoclaves

  • Sterilizers

  • Cleanrooms

  • RABS/Isolators

• Periodic requalification shall be performed as per approved schedule.

8.2.10 Raw Material and Component Control

• Suppliers shall be qualified.

• Incoming materials shall be inspected for contamination risk.

• Materials shall be stored under controlled environmental conditions.

8.2.11 Process and Product Controls

• Bioburden shall be controlled prior to sterilization.

• Sterilization cycles shall be validated.

• Critical in-process parameters shall be monitored.

8.2.12 Waste and Drainage Management

• Closed waste systems shall be used wherever feasible.

• Stagnant water shall be avoided; drainage slope shall be maintained.

• Waste shall be removed without compromising cleanroom integrity.

8.2.13 Pest Control Program

• A documented pest control program shall be maintained.

• Approved baits and traps shall be used outside controlled areas.

• No pesticides shall be used inside sterile zones.

8.2.14 Monitoring, Trending, and Continuous Improvement

• Contamination-related trends shall be reviewed monthly.

• Deviations, EM data, microbial trends, and CAPA shall be evaluated.

• CCS shall be reviewed annually as part of the Pharmaceutical Quality System (PQS).

8.2.15 Numbering System for CCS

The CCS numbering format shall be:

AAA/YY/ZZ/BBB

Where:

• AAA : Contamination Control Strategy (CCS)

• YY : Product code

  • GV – Glass Vial

  • RS – Respule

  • PB – Plastic Bottle

  • FB – Flex Bag

• ZZ : Last two digits of current year (e.g., 2025 = 25)

• BBB : Serial Number (001, 002, etc.)

Examples:

• Glass Vial: CCS/GV/25/001

• Respule: CCS/RS/25/001

• Plastic Bottle: CCS/PB/25/001

• Flex Bag: CCS/FB/25/001

8.2.16 Training

• Personnel shall be trained on:

  • This CCS SOP

  • EU GMP Annex 1 principles

  • Aseptic behavior and contamination risks

• Training effectiveness shall be periodically evaluated and documented.

9.0 ENCLOSURES

Annexure – I
Template of Contamination Control Strategy (CCS)